Pharmaceutical Industry News Archive
Get news By email or subscribe to our News feeds.
November 2009
November 2
November 3
November 4
November 5
Sermo Launches the Practice Management Exchange to Support the New Physician Practice in a Changing Healthcare World
Genmab Reorganizes to Build Sustainable Business
Genmab Revises Financial Guidance
IMS Health to be Acquired by TPG and CPP Investment Board
IMS Health to be Acquired by TPG and CPP Investment Board
November 6
November 9
November 10
Hospira Brand Propofol and Liposyn Products - Recall:Product containers may contain particulate matter that could act as emboli and lead to impeded blood flow
Bristol-Myers Squibb and Alder Biopharmaceuticals Enter Global Agreement on Rheumatoid Arthritis Biologic
PhRMA Statement About Accessing Online Health Information
Basketball Legend Kareem Abdul-Jabbar Announces He Has Been Diagnosed With Chronic Myeloid Leukemia; Aims To Inspire Others
November 12
November 13
Astex Announces Strategic Drug Discovery Alliance with GlaxoSmithKline
BioInvent Signs Licensing Agreement with Daiichi Sankyo for the Discovery and Development of Therapeutic Antibodies
Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor
Drug Companies to Fight Neglected Diseases
Eli Lilly Hires Paul as Chief Researcher
Google Helps You Find A Flu Shot
Cephalon, Barr Settle Fentora Dispute
Google, Yahoo Call for Expanded Online Drug Ads
Swiss OK Novartis Swine Flu Vaccine From Cells
FDA Finds Bits of Steel, Rubber in Genzyme Drugs
November 14
November 16
Bristol-Myers Squibb Announces Split-Off of Mead Johnson
FDA Sends Warning Letters for Dacogen and Fosrenol
Abbott Statement on ARBITER 6 - HALTS Results and Abbott's Niaspan (niacin extended-release)
Particles Detected in Vials from Genzyme's Plant Not Expected to Impact Aldurazyme or Naglazyme
Study Raises New Questions About Merck Pill Zetia
Sanofi-Aventis Swine Flu Vaccine Cleared in France
GlaxoSmithKline, Nabi to Develop Smoking Vaccine
Boehringer Ingelheim Developing 'Female Viagra'
Lilly's Big Cancer Bet: Seeking New Blockbusters
Drug Industry Raises Prices by 9%
Merck Announces Completion of Patient Enrollment in Phase III TRA-2°P-TIMI 50 Trial of SCH 530348, a Novel, Oral Antiplatelet PAR-1 Inhibitor
November 17
Novartis: Lower Dose of Flu Vaccine Sufficient (AP)
FDA Says Prilosec Can Block Benefits of Plavix
Novartis: Lower Dose of Flu Vaccine Sufficient
FDA Reviews Update to Pfizer Vaccine for Kids
Genzyme Flops at FDA: Allston Plant Problems Delay Drug Review [Boston Herald]
Drug Therapy More Cost-Effective Than Angioplasty for Diabetic Patients with Heart Disease, Stanford Researcher Finds
Common Cold Virus May Have Foiled HIV Vaccine Test
FDA and Everyday Health Collaborate to Expand Reach of Consumer Health Information
November 18
FDA Says Heartburn Drugs Can Interfere with Plavix
Vaccines on Horizon for AIDS, Alzheimer's, Herpes
Pfizer Inc Submits New Pediatric Data for Lipitor to EMEA
FDA Approves New Post-Shingles Attack Drug
Pfizer Enters Tropical Disease Drug Partnership
InterMune Shares Fall on Change in Hepatitis Study
Ex-Pharma Executive Runs as Dem for Kansas Governor
November 19
Genentech, Biogen Get FDA Request on Rituxan
AstraZeneca Seeks Brilinta Approval in US
FDA Panel Backs Pfizer's Enhanced Vaccine for Kids
Committee Leaders Call for GAO Analysis of Recent Prescription Drug Price Increases
Time to Blow Up the Pharmaceutical Sales Model? New Deloitte Debate
PhRMA Statement on Misleading Reports About Price Growth
FDA Issues 22 Warning Letters to Web Site Operators
WHO: Swine Flu Shot Not Causing Deaths
FDA Panel Backs Safety, Benefits of Spiriva
November 20
Retiring Lilly Research Exec Steven Paul Gets $2 Million in Severance [The Indianapolis Star]
Moody's Gives Negative View on Pharma Credit
The Botax? Nip/Tuck Levy to Help Health Care Plan
Antitrust Lawyer Files Suit to Stop Pfizer Merger
Saatchi & Saatchi Wellness Names Russell as Managing Director
November 23
Germany's Merck Will Expand R&D in China
GlaxoSmithKline Calls for Suspension of New Flu Vaccinations in Canada
FDA OKs Abilify for Autism-linked Irritability
Tamiflu-resistant Swine Flu Cluster Reported in US
Novartis Increases Staff Pay by 1.5% from April 2010
FDA MedWatch - Meridia (sibutramine): Early Communication about cardiovascular events
Merck KGaA to Expand Research and Development Presence in China
Merck Claims Win in Texas Lawsuit Over Vioxx
Congressional Documents and Publications
November 24
Merck Wins Summary Judgment in Texas Attorney General's Lawsuit Involving Vioxx
Merck Wins Summary Judgment in Second Federal Bellwether Case Involving Fosamax (alendronate sodium)
Novartis: First US Plant for Cell-based Flu Vaccine
Jury Awards $75 Million in Punitive Damages to Illinois Woman in Prempro Cancer Case
Clavis Pharma and Clovis Oncology Sign $380 Million Partnership for the Development and Commercialisation of Anti-Cancer Agent CP-4126
Novartis inaugurates large-scale US based cell-culture influenza vaccine manufacturing facility
First US Plant for Cell-Based Flu Vaccines Opened
Merck Says Key Fosamax Lawsuit Dismissed
GlaxoSmithKline Pulls Application for New Drug Use
Drug Ads Ineffective for Boosting Sales, Could Cost Taxpayers: UBC-Harvard Study
Psychotropic Medications Associated With Risk of Falls in Older Adults
Direct-to-consumer Ads Associated With Higher Medicaid Costs
Gilead and GlaxoSmithKline Announce Agreement to Commercialize Viread for Chronic Hepatitis B in Key Asian Countries
Pfizer Faces $103 Million in Prempro Damages
Gilead Signs Sales Deal With Glaxo for Viread
November 25
Idera Pharmaceuticals Announces Termination of Asthma and Allergy Research Collaboration Agreement
Chugai Revises Corporate Advertisement for First Time in Four Years
Idera Pharmaceuticals and Merck & Co., Inc. Extend Research Collaboration for Agonists of Toll-like Receptors as Vaccine Adjuvants
SDI Reports: Prescriptions for Patients New to Niaspan Rise 41% in Week Following Release of Arbiter 6-HALTS Study Results
November 30
EU Approves Single Dose Swine Flu Vaccine
FDA OK's Agriflu Seasonal Flu Vaccine
Hormone Boosts For Men Get A Test
Sanofi Aventis Will Join Russian Drug Project
Eyelash Drug Might Help Cancer Patients
Theravance Says FDA Delays New Vitabiv Decision
CEO: Bayer Will Not Shy Away From Major Acquisitions
Consumers Pay Little or No Attention to Drug Company's Advertised Risk Disclosures, Latest Under the Skin Study from ORC Guideline Finds
TheBody.com Launches My Health Tracker, Enabling HIV-Positive Patients to Track Lab Results, Medications and Supplements
